Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT01868022
Title	Study to Evaluate GSK3052230 in Combination With Paclitaxel and Carboplatin, or Docetaxel or as Single Agent in Subjects With Solid Malignancies and Deregulated Fibroblast Growth Factor (FGF) Pathway Signaling
Recruitment	Completed
Gender	both
Phase	Phase I
Variant Requirements	Yes
Sponsors	GlaxoSmithKline
Indications	malignant pleural mesothelioma lung non-small cell carcinoma
Therapies	Docetaxel Cisplatin + Pemetrexed Disodium GSK3052230 Carboplatin + Paclitaxel
Age Groups:	adult
Covered Countries	USA \| NLD \| GBR \| ESP \| DNK \| BEL